Compare ROIV & CAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ROIV | CAE |
|---|---|---|
| Founded | 2014 | 1947 |
| Country | United Kingdom | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 8.5B |
| IPO Year | N/A | N/A |
| Metric | ROIV | CAE |
|---|---|---|
| Price | $21.67 | $29.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | $21.94 | ★ $33.75 |
| AVG Volume (30 Days) | ★ 6.7M | 600.9K |
| Earning Date | 11-10-2025 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.97 |
| Revenue | $20,329,000.00 | ★ $3,470,482,234.00 |
| Revenue This Year | N/A | $6.40 |
| Revenue Next Year | $376.94 | $5.69 |
| P/E Ratio | ★ N/A | $30.62 |
| Revenue Growth | N/A | ★ 9.12 |
| 52 Week Low | $8.73 | $20.36 |
| 52 Week High | $22.45 | $30.13 |
| Indicator | ROIV | CAE |
|---|---|---|
| Relative Strength Index (RSI) | 62.44 | 69.86 |
| Support Level | $20.14 | $27.07 |
| Resistance Level | $21.48 | $28.58 |
| Average True Range (ATR) | 0.71 | 0.68 |
| MACD | 0.00 | 0.36 |
| Stochastic Oscillator | 65.96 | 83.82 |
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: Civil Aviation which offers comprehensive training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training, and crew sourcing services, as well as aircraft flight operations solutions; and Defense and Security which is a world-wide training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.